Article Details
Retrieved on: 2021-12-27 14:24:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
China's Kintor Pharmaceutical Ltd said data from a Phase III clinical trial for its potential COVID-19 treatment proxalutamide in non-hospitalised ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here